[1]
B. Memeti, F. Brombacher, L. Perger, and S. Russmann, “Mottling as an early sign of euglycemic ketoacidosis induced by SGLT-2 inhibitors”, EJCRIM, vol. 12, no. 4, Mar. 2025, doi: 10.12890/2025_005210.